Patent · US Expired

Piperidinoalkylbenzoxazine and piperidinoalkylbenzothiazine compounds, and medicaments containing them

US5283243A · kind A · utility

3Cited by
5References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 15, 1991
Grant dateFeb 1, 1994
Priority date
Expiry dateNov 15, 2011

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Pharmacologically active compounds corresponding to the formula I ##STR1## which are optionally substituted in the benzene ring and in which X denotes oxygen or sulfur, PA1 Y denotes oxygen or sulfur, PA1 R.sup.1 denotes hydrogen or lower alkyl, PA1 n is an integer from 0 to 4, PA1 R.sup.4 denotes hydrogen, and PA1 R.sup.5 denotes hydrogen, hydroxy or cyano, or PA1 R.sup.4 and R.sup.5 together form a bond, PA1 R.sup.6 denotes an A--R.sup.7 group in which R.sup.7 denotes an optionally substituted phenyl group, and A denotes a --CH.sub.2 -- group, a CO group or a bond, or PA1 R.sup.6 is a halogen-substituted 1-phenylmethyl-1H-benzimidazol-2-ylamino group, and physiologically acceptable acid addition salts thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.